nodes	percent_of_prediction	percent_of_DWPC	metapath
Lovastatin—ABCC2—Vinblastine—head and neck cancer	0.106	0.158	CbGbCtD
Lovastatin—CYP2D6—Hydroxyurea—head and neck cancer	0.0916	0.137	CbGbCtD
Lovastatin—ABCC2—Docetaxel—head and neck cancer	0.087	0.13	CbGbCtD
Lovastatin—CYP3A7-CYP3A51P—Docetaxel—head and neck cancer	0.0581	0.0867	CbGbCtD
Lovastatin—CYP3A7—Docetaxel—head and neck cancer	0.0581	0.0867	CbGbCtD
Lovastatin—CYP2C8—Fluorouracil—head and neck cancer	0.0549	0.0819	CbGbCtD
Lovastatin—CYP3A5—Docetaxel—head and neck cancer	0.0436	0.0651	CbGbCtD
Lovastatin—CYP2C9—Fluorouracil—head and neck cancer	0.0383	0.0571	CbGbCtD
Lovastatin—ABCB1—Vinblastine—head and neck cancer	0.0344	0.0514	CbGbCtD
Lovastatin—CYP2D6—Vinblastine—head and neck cancer	0.0324	0.0484	CbGbCtD
Lovastatin—ABCB1—Docetaxel—head and neck cancer	0.0284	0.0423	CbGbCtD
Lovastatin—Dermatomyositis—Hydroxyurea—head and neck cancer	0.0218	0.158	CcSEcCtD
Lovastatin—CYP3A4—Vinblastine—head and neck cancer	0.0206	0.0308	CbGbCtD
Lovastatin—CYP3A4—Docetaxel—head and neck cancer	0.017	0.0254	CbGbCtD
Lovastatin—HDAC2—parathyroid gland—head and neck cancer	0.00655	0.092	CbGeAlD
Lovastatin—Lupus erythematosus—Hydroxyurea—head and neck cancer	0.00614	0.0445	CcSEcCtD
Lovastatin—Memory loss—Fluorouracil—head and neck cancer	0.0056	0.0406	CcSEcCtD
Lovastatin—Systemic lupus erythematosus—Hydroxyurea—head and neck cancer	0.00413	0.03	CcSEcCtD
Lovastatin—PON3—parotid gland—head and neck cancer	0.00397	0.0557	CbGeAlD
Lovastatin—PON3—saliva-secreting gland—head and neck cancer	0.0038	0.0534	CbGeAlD
Lovastatin—ITGAL—connective tissue—head and neck cancer	0.00356	0.05	CbGeAlD
Lovastatin—HDAC2—tongue—head and neck cancer	0.00345	0.0485	CbGeAlD
Lovastatin—ITGAL—epithelium—head and neck cancer	0.00338	0.0475	CbGeAlD
Lovastatin—Lupus erythematosus—Docetaxel—head and neck cancer	0.00319	0.0231	CcSEcCtD
Lovastatin—HDAC2—exocrine gland—head and neck cancer	0.0031	0.0436	CbGeAlD
Lovastatin—ITGAL—trachea—head and neck cancer	0.00299	0.042	CbGeAlD
Lovastatin—HDAC2—hair follicle—head and neck cancer	0.00296	0.0416	CbGeAlD
Lovastatin—HMGCR—hair follicle—head and neck cancer	0.00267	0.0375	CbGeAlD
Lovastatin—Tenderness—Hydroxyurea—head and neck cancer	0.00262	0.019	CcSEcCtD
Lovastatin—ITGAL—lymphoid tissue—head and neck cancer	0.0026	0.0366	CbGeAlD
Lovastatin—ITGAL—thyroid gland—head and neck cancer	0.00236	0.0332	CbGeAlD
Lovastatin—HDAC2—mouth—head and neck cancer	0.00232	0.0326	CbGeAlD
Lovastatin—PON3—thyroid gland—head and neck cancer	0.00232	0.0326	CbGeAlD
Lovastatin—Systemic lupus erythematosus—Docetaxel—head and neck cancer	0.00215	0.0156	CcSEcCtD
Lovastatin—HDAC2—neck—head and neck cancer	0.00198	0.0279	CbGeAlD
Lovastatin—Eye irritation—Fluorouracil—head and neck cancer	0.00193	0.014	CcSEcCtD
Lovastatin—Tenderness—Fluorouracil—head and neck cancer	0.00189	0.0137	CcSEcCtD
Lovastatin—Hepatic failure—Hydroxyurea—head and neck cancer	0.00185	0.0134	CcSEcCtD
Lovastatin—HMGCR—neck—head and neck cancer	0.00179	0.0252	CbGeAlD
Lovastatin—HDAC2—saliva-secreting gland—head and neck cancer	0.00155	0.0218	CbGeAlD
Lovastatin—ITGAL—lymph node—head and neck cancer	0.00147	0.0206	CbGeAlD
Lovastatin—HMGCR—parotid gland—head and neck cancer	0.00146	0.0205	CbGeAlD
Lovastatin—HDAC2—connective tissue—head and neck cancer	0.00142	0.02	CbGeAlD
Lovastatin—Pancreatitis—Hydroxyurea—head and neck cancer	0.00141	0.0102	CcSEcCtD
Lovastatin—HMGCR—saliva-secreting gland—head and neck cancer	0.0014	0.0196	CbGeAlD
Lovastatin—Eye irritation—Docetaxel—head and neck cancer	0.00139	0.0101	CcSEcCtD
Lovastatin—Neuropathy peripheral—Vinblastine—head and neck cancer	0.00137	0.00997	CcSEcCtD
Lovastatin—Photosensitivity—Fluorouracil—head and neck cancer	0.00136	0.00987	CcSEcCtD
Lovastatin—HDAC2—epithelium—head and neck cancer	0.00135	0.019	CbGeAlD
Lovastatin—HMGCR—connective tissue—head and neck cancer	0.00128	0.018	CbGeAlD
Lovastatin—Amnesia—Fluorouracil—head and neck cancer	0.00127	0.00922	CcSEcCtD
Lovastatin—Neuropathy peripheral—Hydroxyurea—head and neck cancer	0.00125	0.0091	CcSEcCtD
Lovastatin—HMGCR—epithelium—head and neck cancer	0.00122	0.0171	CbGeAlD
Lovastatin—Phosphatase alkaline increased—Docetaxel—head and neck cancer	0.00119	0.00862	CcSEcCtD
Lovastatin—Alopecia—Vinblastine—head and neck cancer	0.00111	0.00807	CcSEcCtD
Lovastatin—HMGCR—trachea—head and neck cancer	0.00108	0.0151	CbGeAlD
Lovastatin—HDAC2—lymphoid tissue—head and neck cancer	0.00104	0.0146	CbGeAlD
Lovastatin—Chills—Hydroxyurea—head and neck cancer	0.00103	0.00747	CcSEcCtD
Lovastatin—Eosinophilia—Fluorouracil—head and neck cancer	0.00102	0.00742	CcSEcCtD
Lovastatin—Ill-defined disorder—Vinblastine—head and neck cancer	0.00102	0.00738	CcSEcCtD
Lovastatin—Alopecia—Hydroxyurea—head and neck cancer	0.00101	0.00736	CcSEcCtD
Lovastatin—Blood alkaline phosphatase increased—Docetaxel—head and neck cancer	0.000991	0.00719	CcSEcCtD
Lovastatin—Malaise—Vinblastine—head and neck cancer	0.000988	0.00717	CcSEcCtD
Lovastatin—Vertigo—Vinblastine—head and neck cancer	0.000985	0.00714	CcSEcCtD
Lovastatin—Leukopenia—Vinblastine—head and neck cancer	0.000981	0.00712	CcSEcCtD
Lovastatin—Hepatic failure—Docetaxel—head and neck cancer	0.00096	0.00696	CcSEcCtD
Lovastatin—HDAC2—thyroid gland—head and neck cancer	0.000945	0.0133	CbGeAlD
Lovastatin—Photosensitivity reaction—Fluorouracil—head and neck cancer	0.000943	0.00684	CcSEcCtD
Lovastatin—HMGCR—lymphoid tissue—head and neck cancer	0.000938	0.0132	CbGeAlD
Lovastatin—Ill-defined disorder—Hydroxyurea—head and neck cancer	0.000927	0.00673	CcSEcCtD
Lovastatin—Discomfort—Vinblastine—head and neck cancer	0.000922	0.00669	CcSEcCtD
Lovastatin—Neuropathy peripheral—Fluorouracil—head and neck cancer	0.000902	0.00655	CcSEcCtD
Lovastatin—Malaise—Hydroxyurea—head and neck cancer	0.000901	0.00654	CcSEcCtD
Lovastatin—Urinary tract infection—Fluorouracil—head and neck cancer	0.000895	0.00649	CcSEcCtD
Lovastatin—Leukopenia—Hydroxyurea—head and neck cancer	0.000895	0.00649	CcSEcCtD
Lovastatin—Thrombocytopenia—Vinblastine—head and neck cancer	0.000876	0.00635	CcSEcCtD
Lovastatin—Sinusitis—Fluorouracil—head and neck cancer	0.000864	0.00627	CcSEcCtD
Lovastatin—Pain in extremity—Docetaxel—head and neck cancer	0.000862	0.00626	CcSEcCtD
Lovastatin—Anorexia—Vinblastine—head and neck cancer	0.000853	0.00619	CcSEcCtD
Lovastatin—HMGCR—thyroid gland—head and neck cancer	0.000852	0.012	CbGeAlD
Lovastatin—Discomfort—Hydroxyurea—head and neck cancer	0.000841	0.0061	CcSEcCtD
Lovastatin—HDAC2—head—head and neck cancer	0.000838	0.0118	CbGeAlD
Lovastatin—Infection—Hydroxyurea—head and neck cancer	0.00081	0.00588	CcSEcCtD
Lovastatin—Paraesthesia—Vinblastine—head and neck cancer	0.000803	0.00583	CcSEcCtD
Lovastatin—Thrombocytopenia—Hydroxyurea—head and neck cancer	0.000799	0.00579	CcSEcCtD
Lovastatin—Anorexia—Hydroxyurea—head and neck cancer	0.000778	0.00564	CcSEcCtD
Lovastatin—Decreased appetite—Vinblastine—head and neck cancer	0.000778	0.00564	CcSEcCtD
Lovastatin—Cramp muscle—Docetaxel—head and neck cancer	0.000776	0.00563	CcSEcCtD
Lovastatin—Toxic epidermal necrolysis—Docetaxel—head and neck cancer	0.000776	0.00563	CcSEcCtD
Lovastatin—Pain—Vinblastine—head and neck cancer	0.000765	0.00555	CcSEcCtD
Lovastatin—Constipation—Vinblastine—head and neck cancer	0.000765	0.00555	CcSEcCtD
Lovastatin—HMGCR—head—head and neck cancer	0.000756	0.0106	CbGeAlD
Lovastatin—Feeling abnormal—Vinblastine—head and neck cancer	0.000737	0.00535	CcSEcCtD
Lovastatin—Gastrointestinal pain—Vinblastine—head and neck cancer	0.000731	0.00531	CcSEcCtD
Lovastatin—Alopecia—Fluorouracil—head and neck cancer	0.00073	0.0053	CcSEcCtD
Lovastatin—Dyspnoea—Hydroxyurea—head and neck cancer	0.000727	0.00528	CcSEcCtD
Lovastatin—Dyspepsia—Hydroxyurea—head and neck cancer	0.000718	0.00521	CcSEcCtD
Lovastatin—Decreased appetite—Hydroxyurea—head and neck cancer	0.000709	0.00514	CcSEcCtD
Lovastatin—Abdominal pain—Vinblastine—head and neck cancer	0.000707	0.00513	CcSEcCtD
Lovastatin—Fatigue—Hydroxyurea—head and neck cancer	0.000703	0.0051	CcSEcCtD
Lovastatin—Constipation—Hydroxyurea—head and neck cancer	0.000698	0.00506	CcSEcCtD
Lovastatin—Pain—Hydroxyurea—head and neck cancer	0.000698	0.00506	CcSEcCtD
Lovastatin—Vision blurred—Fluorouracil—head and neck cancer	0.000678	0.00492	CcSEcCtD
Lovastatin—Feeling abnormal—Hydroxyurea—head and neck cancer	0.000672	0.00488	CcSEcCtD
Lovastatin—Hypersensitivity—Vinblastine—head and neck cancer	0.000659	0.00478	CcSEcCtD
Lovastatin—Stevens-Johnson syndrome—Docetaxel—head and neck cancer	0.000659	0.00478	CcSEcCtD
Lovastatin—Neuropathy peripheral—Docetaxel—head and neck cancer	0.000651	0.00473	CcSEcCtD
Lovastatin—Body temperature increased—Hydroxyurea—head and neck cancer	0.000645	0.00468	CcSEcCtD
Lovastatin—Leukopenia—Fluorouracil—head and neck cancer	0.000644	0.00467	CcSEcCtD
Lovastatin—Asthenia—Vinblastine—head and neck cancer	0.000642	0.00466	CcSEcCtD
Lovastatin—Myalgia—Fluorouracil—head and neck cancer	0.000613	0.00444	CcSEcCtD
Lovastatin—Chest pain—Fluorouracil—head and neck cancer	0.000613	0.00444	CcSEcCtD
Lovastatin—Diarrhoea—Vinblastine—head and neck cancer	0.000612	0.00444	CcSEcCtD
Lovastatin—Discomfort—Fluorouracil—head and neck cancer	0.000605	0.00439	CcSEcCtD
Lovastatin—Hypersensitivity—Hydroxyurea—head and neck cancer	0.000601	0.00436	CcSEcCtD
Lovastatin—Hepatitis—Docetaxel—head and neck cancer	0.000597	0.00433	CcSEcCtD
Lovastatin—Confusional state—Fluorouracil—head and neck cancer	0.000592	0.0043	CcSEcCtD
Lovastatin—Dizziness—Vinblastine—head and neck cancer	0.000592	0.00429	CcSEcCtD
Lovastatin—SLCO1A2—head—head and neck cancer	0.00059	0.00829	CbGeAlD
Lovastatin—Anaphylactic shock—Fluorouracil—head and neck cancer	0.000587	0.00426	CcSEcCtD
Lovastatin—HDAC2—lymph node—head and neck cancer	0.000587	0.00825	CbGeAlD
Lovastatin—Asthenia—Hydroxyurea—head and neck cancer	0.000585	0.00425	CcSEcCtD
Lovastatin—Infection—Fluorouracil—head and neck cancer	0.000583	0.00423	CcSEcCtD
Lovastatin—Thrombocytopenia—Fluorouracil—head and neck cancer	0.000575	0.00417	CcSEcCtD
Lovastatin—Vomiting—Vinblastine—head and neck cancer	0.000569	0.00413	CcSEcCtD
Lovastatin—Erythema multiforme—Docetaxel—head and neck cancer	0.000564	0.00409	CcSEcCtD
Lovastatin—Headache—Vinblastine—head and neck cancer	0.00056	0.00407	CcSEcCtD
Lovastatin—Anorexia—Fluorouracil—head and neck cancer	0.00056	0.00406	CcSEcCtD
Lovastatin—Diarrhoea—Hydroxyurea—head and neck cancer	0.000558	0.00405	CcSEcCtD
Lovastatin—Flushing—Docetaxel—head and neck cancer	0.000554	0.00402	CcSEcCtD
Lovastatin—Dizziness—Hydroxyurea—head and neck cancer	0.000539	0.00391	CcSEcCtD
Lovastatin—Chills—Docetaxel—head and neck cancer	0.000535	0.00388	CcSEcCtD
Lovastatin—Musculoskeletal discomfort—Fluorouracil—head and neck cancer	0.000535	0.00388	CcSEcCtD
Lovastatin—Nausea—Vinblastine—head and neck cancer	0.000531	0.00385	CcSEcCtD
Lovastatin—Insomnia—Fluorouracil—head and neck cancer	0.000531	0.00385	CcSEcCtD
Lovastatin—HMGCR—lymph node—head and neck cancer	0.000529	0.00744	CbGeAlD
Lovastatin—Paraesthesia—Fluorouracil—head and neck cancer	0.000527	0.00382	CcSEcCtD
Lovastatin—Alopecia—Docetaxel—head and neck cancer	0.000527	0.00382	CcSEcCtD
Lovastatin—Dyspnoea—Fluorouracil—head and neck cancer	0.000523	0.0038	CcSEcCtD
Lovastatin—Vomiting—Hydroxyurea—head and neck cancer	0.000519	0.00376	CcSEcCtD
Lovastatin—Dyspepsia—Fluorouracil—head and neck cancer	0.000517	0.00375	CcSEcCtD
Lovastatin—Rash—Hydroxyurea—head and neck cancer	0.000514	0.00373	CcSEcCtD
Lovastatin—Dermatitis—Hydroxyurea—head and neck cancer	0.000514	0.00373	CcSEcCtD
Lovastatin—Headache—Hydroxyurea—head and neck cancer	0.000511	0.00371	CcSEcCtD
Lovastatin—Decreased appetite—Fluorouracil—head and neck cancer	0.00051	0.0037	CcSEcCtD
Lovastatin—Dysgeusia—Docetaxel—head and neck cancer	0.000509	0.00369	CcSEcCtD
Lovastatin—Back pain—Docetaxel—head and neck cancer	0.000502	0.00364	CcSEcCtD
Lovastatin—Pain—Fluorouracil—head and neck cancer	0.000502	0.00364	CcSEcCtD
Lovastatin—Muscle spasms—Docetaxel—head and neck cancer	0.000499	0.00362	CcSEcCtD
Lovastatin—Nausea—Hydroxyurea—head and neck cancer	0.000485	0.00352	CcSEcCtD
Lovastatin—Feeling abnormal—Fluorouracil—head and neck cancer	0.000484	0.00351	CcSEcCtD
Lovastatin—Urticaria—Fluorouracil—head and neck cancer	0.000466	0.00338	CcSEcCtD
Lovastatin—Leukopenia—Docetaxel—head and neck cancer	0.000465	0.00337	CcSEcCtD
Lovastatin—Body temperature increased—Fluorouracil—head and neck cancer	0.000464	0.00337	CcSEcCtD
Lovastatin—Arthralgia—Docetaxel—head and neck cancer	0.000442	0.00321	CcSEcCtD
Lovastatin—Myalgia—Docetaxel—head and neck cancer	0.000442	0.00321	CcSEcCtD
Lovastatin—Chest pain—Docetaxel—head and neck cancer	0.000442	0.00321	CcSEcCtD
Lovastatin—Hypersensitivity—Fluorouracil—head and neck cancer	0.000433	0.00314	CcSEcCtD
Lovastatin—Dry mouth—Docetaxel—head and neck cancer	0.000432	0.00314	CcSEcCtD
Lovastatin—Confusional state—Docetaxel—head and neck cancer	0.000427	0.0031	CcSEcCtD
Lovastatin—Anaphylactic shock—Docetaxel—head and neck cancer	0.000424	0.00307	CcSEcCtD
Lovastatin—Infection—Docetaxel—head and neck cancer	0.000421	0.00305	CcSEcCtD
Lovastatin—Pruritus—Fluorouracil—head and neck cancer	0.000415	0.00301	CcSEcCtD
Lovastatin—Thrombocytopenia—Docetaxel—head and neck cancer	0.000415	0.00301	CcSEcCtD
Lovastatin—Anorexia—Docetaxel—head and neck cancer	0.000404	0.00293	CcSEcCtD
Lovastatin—Diarrhoea—Fluorouracil—head and neck cancer	0.000402	0.00291	CcSEcCtD
Lovastatin—Dizziness—Fluorouracil—head and neck cancer	0.000388	0.00282	CcSEcCtD
Lovastatin—Musculoskeletal discomfort—Docetaxel—head and neck cancer	0.000386	0.0028	CcSEcCtD
Lovastatin—ABCC2—lymph node—head and neck cancer	0.000385	0.0054	CbGeAlD
Lovastatin—Insomnia—Docetaxel—head and neck cancer	0.000383	0.00278	CcSEcCtD
Lovastatin—Paraesthesia—Docetaxel—head and neck cancer	0.000381	0.00276	CcSEcCtD
Lovastatin—Dyspnoea—Docetaxel—head and neck cancer	0.000378	0.00274	CcSEcCtD
Lovastatin—Vomiting—Fluorouracil—head and neck cancer	0.000373	0.00271	CcSEcCtD
Lovastatin—Dyspepsia—Docetaxel—head and neck cancer	0.000373	0.00271	CcSEcCtD
Lovastatin—Rash—Fluorouracil—head and neck cancer	0.00037	0.00269	CcSEcCtD
Lovastatin—Dermatitis—Fluorouracil—head and neck cancer	0.00037	0.00268	CcSEcCtD
Lovastatin—Decreased appetite—Docetaxel—head and neck cancer	0.000368	0.00267	CcSEcCtD
Lovastatin—Headache—Fluorouracil—head and neck cancer	0.000368	0.00267	CcSEcCtD
Lovastatin—Fatigue—Docetaxel—head and neck cancer	0.000365	0.00265	CcSEcCtD
Lovastatin—Pain—Docetaxel—head and neck cancer	0.000362	0.00263	CcSEcCtD
Lovastatin—Constipation—Docetaxel—head and neck cancer	0.000362	0.00263	CcSEcCtD
Lovastatin—Feeling abnormal—Docetaxel—head and neck cancer	0.000349	0.00253	CcSEcCtD
Lovastatin—Nausea—Fluorouracil—head and neck cancer	0.000349	0.00253	CcSEcCtD
Lovastatin—Gastrointestinal pain—Docetaxel—head and neck cancer	0.000347	0.00251	CcSEcCtD
Lovastatin—Abdominal pain—Docetaxel—head and neck cancer	0.000335	0.00243	CcSEcCtD
Lovastatin—Body temperature increased—Docetaxel—head and neck cancer	0.000335	0.00243	CcSEcCtD
Lovastatin—ABCB1—epithelium—head and neck cancer	0.000318	0.00447	CbGeAlD
Lovastatin—Hypersensitivity—Docetaxel—head and neck cancer	0.000312	0.00227	CcSEcCtD
Lovastatin—Asthenia—Docetaxel—head and neck cancer	0.000304	0.00221	CcSEcCtD
Lovastatin—Pruritus—Docetaxel—head and neck cancer	0.0003	0.00218	CcSEcCtD
Lovastatin—Diarrhoea—Docetaxel—head and neck cancer	0.00029	0.0021	CcSEcCtD
Lovastatin—ABCB1—trachea—head and neck cancer	0.000281	0.00395	CbGeAlD
Lovastatin—Dizziness—Docetaxel—head and neck cancer	0.00028	0.00203	CcSEcCtD
Lovastatin—CYP2D6—head—head and neck cancer	0.000275	0.00386	CbGeAlD
Lovastatin—Vomiting—Docetaxel—head and neck cancer	0.000269	0.00195	CcSEcCtD
Lovastatin—Rash—Docetaxel—head and neck cancer	0.000267	0.00194	CcSEcCtD
Lovastatin—Dermatitis—Docetaxel—head and neck cancer	0.000267	0.00194	CcSEcCtD
Lovastatin—Headache—Docetaxel—head and neck cancer	0.000266	0.00193	CcSEcCtD
Lovastatin—Nausea—Docetaxel—head and neck cancer	0.000252	0.00183	CcSEcCtD
Lovastatin—ABCB1—lymphoid tissue—head and neck cancer	0.000245	0.00344	CbGeAlD
Lovastatin—ABCB1—thyroid gland—head and neck cancer	0.000223	0.00313	CbGeAlD
Lovastatin—ABCB1—head—head and neck cancer	0.000197	0.00278	CbGeAlD
Lovastatin—ABCB1—lymph node—head and neck cancer	0.000138	0.00194	CbGeAlD
Lovastatin—CYP2C9—Biological oxidations—CYP1A1—head and neck cancer	8.61e-05	0.000712	CbGpPWpGaD
Lovastatin—CYP2D6—Metapathway biotransformation—CYP1A1—head and neck cancer	8.56e-05	0.000708	CbGpPWpGaD
Lovastatin—CYP2C9—Metapathway biotransformation—CYP1A1—head and neck cancer	8.49e-05	0.000702	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—GRP—head and neck cancer	8.43e-05	0.000698	CbGpPWpGaD
Lovastatin—HDAC2—Signaling by NGF—MAPK3—head and neck cancer	8.41e-05	0.000696	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	8.35e-05	0.000691	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—UROD—head and neck cancer	8.3e-05	0.000687	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	8.27e-05	0.000684	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—STAT6—head and neck cancer	8.19e-05	0.000677	CbGpPWpGaD
Lovastatin—HMGCR—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	8.14e-05	0.000674	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—UROD—head and neck cancer	8.11e-05	0.00067	CbGpPWpGaD
Lovastatin—ABCB1—Allograft Rejection—VEGFA—head and neck cancer	8.04e-05	0.000665	CbGpPWpGaD
Lovastatin—HDAC2—Signaling by NGF—MAPK1—head and neck cancer	8e-05	0.000662	CbGpPWpGaD
Lovastatin—HDAC2—Signaling by NGF—EGFR—head and neck cancer	8e-05	0.000662	CbGpPWpGaD
Lovastatin—UGT2B7—Metabolism—DPYD—head and neck cancer	7.92e-05	0.000655	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism—NAT2—head and neck cancer	7.86e-05	0.00065	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—UROD—head and neck cancer	7.64e-05	0.000632	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—UROD—head and neck cancer	7.57e-05	0.000626	CbGpPWpGaD
Lovastatin—UGT2B7—Metabolism—YAP1—head and neck cancer	7.51e-05	0.000621	CbGpPWpGaD
Lovastatin—ITGAL—Immune System—PIK3CA—head and neck cancer	7.51e-05	0.000621	CbGpPWpGaD
Lovastatin—UGT1A1—Metabolism—NAT2—head and neck cancer	7.34e-05	0.000607	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—YAP1—head and neck cancer	7.25e-05	0.000599	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	7.22e-05	0.000597	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	7.14e-05	0.000591	CbGpPWpGaD
Lovastatin—HMGCR—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	7.1e-05	0.000588	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	7.07e-05	0.000585	CbGpPWpGaD
Lovastatin—HDAC2—Signaling by NGF—PIK3CA—head and neck cancer	6.94e-05	0.000574	CbGpPWpGaD
Lovastatin—ITGAL—Immune System—HRAS—head and neck cancer	6.94e-05	0.000574	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism—DPYD—head and neck cancer	6.89e-05	0.00057	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—NAT2—head and neck cancer	6.72e-05	0.000556	CbGpPWpGaD
Lovastatin—HDAC2—Hemostasis—IL2—head and neck cancer	6.63e-05	0.000548	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism—YAP1—head and neck cancer	6.54e-05	0.000541	CbGpPWpGaD
Lovastatin—HMGCR—Metabolism—TYMS—head and neck cancer	6.51e-05	0.000538	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	6.44e-05	0.000533	CbGpPWpGaD
Lovastatin—HMGCR—Metabolism—GSTM1—head and neck cancer	6.43e-05	0.000532	CbGpPWpGaD
Lovastatin—UGT1A1—Metabolism—DPYD—head and neck cancer	6.43e-05	0.000532	CbGpPWpGaD
Lovastatin—HDAC2—Signaling by NGF—HRAS—head and neck cancer	6.43e-05	0.000531	CbGpPWpGaD
Lovastatin—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—head and neck cancer	6.18e-05	0.000511	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—NAT2—head and neck cancer	6.17e-05	0.00051	CbGpPWpGaD
Lovastatin—HMGCR—Metabolism—GPX1—head and neck cancer	6.16e-05	0.00051	CbGpPWpGaD
Lovastatin—ITGAL—Immune System—AKT1—head and neck cancer	6.13e-05	0.000507	CbGpPWpGaD
Lovastatin—UGT1A1—Metabolism—YAP1—head and neck cancer	6.1e-05	0.000505	CbGpPWpGaD
Lovastatin—HMGCR—Metabolism—CYP1A1—head and neck cancer	6.1e-05	0.000504	CbGpPWpGaD
Lovastatin—CYP3A4—Biological oxidations—GSTM1—head and neck cancer	5.99e-05	0.000495	CbGpPWpGaD
Lovastatin—ABCB1—HIF-1-alpha transcription factor network—AKT1—head and neck cancer	5.93e-05	0.00049	CbGpPWpGaD
Lovastatin—CYP3A4—Metapathway biotransformation—GSTM1—head and neck cancer	5.91e-05	0.000489	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—DPYD—head and neck cancer	5.9e-05	0.000488	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	5.87e-05	0.000486	CbGpPWpGaD
Lovastatin—CYP3A4—Biological oxidations—CYP1A1—head and neck cancer	5.68e-05	0.00047	CbGpPWpGaD
Lovastatin—HDAC2—Signaling by NGF—AKT1—head and neck cancer	5.67e-05	0.000469	CbGpPWpGaD
Lovastatin—HDAC2—Hemostasis—VEGFA—head and neck cancer	5.63e-05	0.000466	CbGpPWpGaD
Lovastatin—CYP3A4—Metapathway biotransformation—CYP1A1—head and neck cancer	5.6e-05	0.000463	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—YAP1—head and neck cancer	5.59e-05	0.000463	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—DPYD—head and neck cancer	5.41e-05	0.000448	CbGpPWpGaD
Lovastatin—HDAC2—Hemostasis—MAPK3—head and neck cancer	5.33e-05	0.000441	CbGpPWpGaD
Lovastatin—UGT1A3—Metabolism—TYMS—head and neck cancer	5.31e-05	0.000439	CbGpPWpGaD
Lovastatin—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—head and neck cancer	5.3e-05	0.000439	CbGpPWpGaD
Lovastatin—UGT1A3—Metabolism—GSTM1—head and neck cancer	5.24e-05	0.000434	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—YAP1—head and neck cancer	5.13e-05	0.000425	CbGpPWpGaD
Lovastatin—HDAC2—Hemostasis—MAPK1—head and neck cancer	5.07e-05	0.000419	CbGpPWpGaD
Lovastatin—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—head and neck cancer	5.04e-05	0.000417	CbGpPWpGaD
Lovastatin—UGT1A3—Metabolism—GPX1—head and neck cancer	5.02e-05	0.000415	CbGpPWpGaD
Lovastatin—HDAC2—Gene Expression—NOTCH1—head and neck cancer	5.02e-05	0.000415	CbGpPWpGaD
Lovastatin—HMGCR—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	5.01e-05	0.000414	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—UROD—head and neck cancer	4.99e-05	0.000413	CbGpPWpGaD
Lovastatin—UGT1A3—Metabolism—CYP1A1—head and neck cancer	4.97e-05	0.000411	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	4.92e-05	0.000407	CbGpPWpGaD
Lovastatin—HDAC2—Disease—NOTCH1—head and neck cancer	4.66e-05	0.000386	CbGpPWpGaD
Lovastatin—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—head and neck cancer	4.55e-05	0.000377	CbGpPWpGaD
Lovastatin—UGT2B7—Metabolism—TYMS—head and neck cancer	4.51e-05	0.000373	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—NAT2—head and neck cancer	4.46e-05	0.000369	CbGpPWpGaD
Lovastatin—UGT2B7—Metabolism—GSTM1—head and neck cancer	4.46e-05	0.000369	CbGpPWpGaD
Lovastatin—HDAC2—Hemostasis—PIK3CA—head and neck cancer	4.4e-05	0.000364	CbGpPWpGaD
Lovastatin—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—head and neck cancer	4.39e-05	0.000364	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	4.29e-05	0.000355	CbGpPWpGaD
Lovastatin—UGT2B7—Metabolism—GPX1—head and neck cancer	4.27e-05	0.000353	CbGpPWpGaD
Lovastatin—HDAC2—Hemostasis—TP53—head and neck cancer	4.26e-05	0.000352	CbGpPWpGaD
Lovastatin—UGT2B7—Metabolism—CYP1A1—head and neck cancer	4.23e-05	0.00035	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	4.2e-05	0.000348	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	4.1e-05	0.000339	CbGpPWpGaD
Lovastatin—HDAC2—Hemostasis—HRAS—head and neck cancer	4.07e-05	0.000337	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	4.06e-05	0.000336	CbGpPWpGaD
Lovastatin—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—head and neck cancer	3.97e-05	0.000328	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism—TYMS—head and neck cancer	3.93e-05	0.000325	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—DPYD—head and neck cancer	3.91e-05	0.000324	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism—GSTM1—head and neck cancer	3.88e-05	0.000321	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—NAT2—head and neck cancer	3.86e-05	0.00032	CbGpPWpGaD
Lovastatin—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—head and neck cancer	3.75e-05	0.000311	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism—GPX1—head and neck cancer	3.72e-05	0.000308	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—YAP1—head and neck cancer	3.71e-05	0.000307	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism—CYP1A1—head and neck cancer	3.68e-05	0.000304	CbGpPWpGaD
Lovastatin—UGT1A1—Metabolism—TYMS—head and neck cancer	3.67e-05	0.000303	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	3.67e-05	0.000303	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	3.66e-05	0.000303	CbGpPWpGaD
Lovastatin—HMGCR—Metabolism—PTGS2—head and neck cancer	3.63e-05	0.0003	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	3.63e-05	0.0003	CbGpPWpGaD
Lovastatin—UGT1A1—Metabolism—GSTM1—head and neck cancer	3.62e-05	0.0003	CbGpPWpGaD
Lovastatin—HDAC2—Hemostasis—AKT1—head and neck cancer	3.59e-05	0.000297	CbGpPWpGaD
Lovastatin—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—head and neck cancer	3.57e-05	0.000296	CbGpPWpGaD
Lovastatin—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—head and neck cancer	3.57e-05	0.000295	CbGpPWpGaD
Lovastatin—UGT1A1—Metabolism—GPX1—head and neck cancer	3.47e-05	0.000287	CbGpPWpGaD
Lovastatin—HDAC2—Disease—PTGS2—head and neck cancer	3.46e-05	0.000286	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—NAT2—head and neck cancer	3.45e-05	0.000285	CbGpPWpGaD
Lovastatin—UGT1A1—Metabolism—CYP1A1—head and neck cancer	3.44e-05	0.000284	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—DPYD—head and neck cancer	3.39e-05	0.00028	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—NAT2—head and neck cancer	3.37e-05	0.000278	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—TYMS—head and neck cancer	3.36e-05	0.000278	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	3.34e-05	0.000276	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—GSTM1—head and neck cancer	3.32e-05	0.000275	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	3.31e-05	0.000273	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—NOTCH1—head and neck cancer	3.27e-05	0.00027	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—YAP1—head and neck cancer	3.21e-05	0.000266	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—GPX1—head and neck cancer	3.18e-05	0.000263	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—NAT2—head and neck cancer	3.17e-05	0.000262	CbGpPWpGaD
Lovastatin—HMGCR—Metabolism—PTEN—head and neck cancer	3.16e-05	0.000262	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—CYP1A1—head and neck cancer	3.15e-05	0.00026	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—NAT2—head and neck cancer	3.14e-05	0.00026	CbGpPWpGaD
Lovastatin—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—head and neck cancer	3.1e-05	0.000256	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—TYMS—head and neck cancer	3.08e-05	0.000255	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—GSTM1—head and neck cancer	3.05e-05	0.000252	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	3.02e-05	0.00025	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—DPYD—head and neck cancer	3.02e-05	0.00025	CbGpPWpGaD
Lovastatin—HDAC2—Disease—PTEN—head and neck cancer	3.02e-05	0.00025	CbGpPWpGaD
Lovastatin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—head and neck cancer	3e-05	0.000248	CbGpPWpGaD
Lovastatin—UGT1A3—Metabolism—PTGS2—head and neck cancer	2.96e-05	0.000245	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—DPYD—head and neck cancer	2.95e-05	0.000244	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—GPX1—head and neck cancer	2.92e-05	0.000241	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—CYP1A1—head and neck cancer	2.89e-05	0.000239	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—YAP1—head and neck cancer	2.87e-05	0.000237	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—YAP1—head and neck cancer	2.8e-05	0.000232	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—DPYD—head and neck cancer	2.78e-05	0.00023	CbGpPWpGaD
Lovastatin—HDAC2—Gene Expression—MAPK3—head and neck cancer	2.78e-05	0.00023	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—DPYD—head and neck cancer	2.76e-05	0.000228	CbGpPWpGaD
Lovastatin—HDAC2—Disease—STAT3—head and neck cancer	2.7e-05	0.000223	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—YAP1—head and neck cancer	2.64e-05	0.000218	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—YAP1—head and neck cancer	2.62e-05	0.000216	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	2.59e-05	0.000214	CbGpPWpGaD
Lovastatin—HDAC2—Disease—MAPK3—head and neck cancer	2.58e-05	0.000213	CbGpPWpGaD
Lovastatin—UGT1A3—Metabolism—PTEN—head and neck cancer	2.58e-05	0.000213	CbGpPWpGaD
Lovastatin—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—head and neck cancer	2.53e-05	0.00021	CbGpPWpGaD
Lovastatin—UGT2B7—Metabolism—PTGS2—head and neck cancer	2.51e-05	0.000208	CbGpPWpGaD
Lovastatin—HDAC2—Disease—MAPK1—head and neck cancer	2.45e-05	0.000203	CbGpPWpGaD
Lovastatin—HDAC2—Disease—EGFR—head and neck cancer	2.45e-05	0.000203	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	2.42e-05	0.0002	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—IL2—head and neck cancer	2.25e-05	0.000186	CbGpPWpGaD
Lovastatin—HMGCR—Metabolism—PIK3CA—head and neck cancer	2.23e-05	0.000185	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—TYMS—head and neck cancer	2.23e-05	0.000184	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—GSTM1—head and neck cancer	2.2e-05	0.000182	CbGpPWpGaD
Lovastatin—UGT2B7—Metabolism—PTEN—head and neck cancer	2.19e-05	0.000181	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—CCND1—head and neck cancer	2.19e-05	0.000181	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism—PTGS2—head and neck cancer	2.19e-05	0.000181	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	2.16e-05	0.000178	CbGpPWpGaD
Lovastatin—HDAC2—Disease—PIK3CA—head and neck cancer	2.13e-05	0.000176	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—PTEN—head and neck cancer	2.11e-05	0.000175	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—GPX1—head and neck cancer	2.11e-05	0.000175	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	2.11e-05	0.000174	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—CYP1A1—head and neck cancer	2.09e-05	0.000173	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—NAT2—head and neck cancer	2.07e-05	0.000172	CbGpPWpGaD
Lovastatin—UGT1A1—Metabolism—PTGS2—head and neck cancer	2.04e-05	0.000169	CbGpPWpGaD
Lovastatin—HDAC2—Disease—HRAS—head and neck cancer	1.97e-05	0.000163	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	1.97e-05	0.000163	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—TYMS—head and neck cancer	1.93e-05	0.00016	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—VEGFA—head and neck cancer	1.91e-05	0.000158	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism—PTEN—head and neck cancer	1.91e-05	0.000158	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—GSTM1—head and neck cancer	1.91e-05	0.000158	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—STAT3—head and neck cancer	1.89e-05	0.000156	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	1.88e-05	0.000156	CbGpPWpGaD
Lovastatin—HDAC2—Gene Expression—AKT1—head and neck cancer	1.87e-05	0.000155	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—PTGS2—head and neck cancer	1.87e-05	0.000155	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—GPX1—head and neck cancer	1.83e-05	0.000151	CbGpPWpGaD
Lovastatin—HMGCR—Metabolism—AKT1—head and neck cancer	1.82e-05	0.000151	CbGpPWpGaD
Lovastatin—UGT1A3—Metabolism—PIK3CA—head and neck cancer	1.82e-05	0.00015	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—DPYD—head and neck cancer	1.82e-05	0.00015	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—CYP1A1—head and neck cancer	1.81e-05	0.00015	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—MAPK3—head and neck cancer	1.81e-05	0.000149	CbGpPWpGaD
Lovastatin—UGT1A1—Metabolism—PTEN—head and neck cancer	1.78e-05	0.000147	CbGpPWpGaD
Lovastatin—HDAC2—Disease—AKT1—head and neck cancer	1.74e-05	0.000144	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—YAP1—head and neck cancer	1.73e-05	0.000143	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—TYMS—head and neck cancer	1.72e-05	0.000143	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—MAPK1—head and neck cancer	1.72e-05	0.000142	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—EGFR—head and neck cancer	1.72e-05	0.000142	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—PTGS2—head and neck cancer	1.72e-05	0.000142	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	1.71e-05	0.000142	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—GSTM1—head and neck cancer	1.7e-05	0.000141	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—TYMS—head and neck cancer	1.68e-05	0.000139	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—GSTM1—head and neck cancer	1.66e-05	0.000138	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—PTEN—head and neck cancer	1.63e-05	0.000135	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—GPX1—head and neck cancer	1.63e-05	0.000135	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—CYP1A1—head and neck cancer	1.61e-05	0.000134	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—GPX1—head and neck cancer	1.59e-05	0.000132	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—TYMS—head and neck cancer	1.58e-05	0.000131	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—CYP1A1—head and neck cancer	1.58e-05	0.00013	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—TYMS—head and neck cancer	1.57e-05	0.00013	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—GSTM1—head and neck cancer	1.57e-05	0.00013	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—GSTM1—head and neck cancer	1.55e-05	0.000128	CbGpPWpGaD
Lovastatin—UGT2B7—Metabolism—PIK3CA—head and neck cancer	1.55e-05	0.000128	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—GPX1—head and neck cancer	1.5e-05	0.000124	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—PTEN—head and neck cancer	1.5e-05	0.000124	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—PIK3CA—head and neck cancer	1.49e-05	0.000123	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—GPX1—head and neck cancer	1.49e-05	0.000123	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	1.49e-05	0.000123	CbGpPWpGaD
Lovastatin—UGT1A3—Metabolism—AKT1—head and neck cancer	1.49e-05	0.000123	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—CYP1A1—head and neck cancer	1.48e-05	0.000123	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—CYP1A1—head and neck cancer	1.47e-05	0.000122	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—TP53—head and neck cancer	1.44e-05	0.000119	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—HRAS—head and neck cancer	1.38e-05	0.000114	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism—PIK3CA—head and neck cancer	1.35e-05	0.000111	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	1.33e-05	0.00011	CbGpPWpGaD
Lovastatin—UGT2B7—Metabolism—AKT1—head and neck cancer	1.26e-05	0.000105	CbGpPWpGaD
Lovastatin—UGT1A1—Metabolism—PIK3CA—head and neck cancer	1.26e-05	0.000104	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—PTGS2—head and neck cancer	1.24e-05	0.000103	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—AKT1—head and neck cancer	1.22e-05	0.000101	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	1.21e-05	0.0001	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—PIK3CA—head and neck cancer	1.15e-05	9.53e-05	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism—AKT1—head and neck cancer	1.1e-05	9.1e-05	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—PTEN—head and neck cancer	1.08e-05	8.96e-05	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—PTGS2—head and neck cancer	1.08e-05	8.9e-05	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—PIK3CA—head and neck cancer	1.06e-05	8.74e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—TYMS—head and neck cancer	1.04e-05	8.57e-05	CbGpPWpGaD
Lovastatin—UGT1A1—Metabolism—AKT1—head and neck cancer	1.03e-05	8.49e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—GSTM1—head and neck cancer	1.02e-05	8.47e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—GPX1—head and neck cancer	9.81e-06	8.11e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—CYP1A1—head and neck cancer	9.71e-06	8.03e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—PTGS2—head and neck cancer	9.6e-06	7.94e-05	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—AKT1—head and neck cancer	9.41e-06	7.78e-05	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—PTEN—head and neck cancer	9.38e-06	7.76e-05	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—PTGS2—head and neck cancer	9.37e-06	7.75e-05	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—PTGS2—head and neck cancer	8.83e-06	7.3e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—PTGS2—head and neck cancer	8.75e-06	7.24e-05	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—AKT1—head and neck cancer	8.63e-06	7.14e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—PTEN—head and neck cancer	8.37e-06	6.93e-05	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—PTEN—head and neck cancer	8.17e-06	6.76e-05	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—PTEN—head and neck cancer	7.7e-06	6.37e-05	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—PIK3CA—head and neck cancer	7.64e-06	6.32e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—PTEN—head and neck cancer	7.63e-06	6.32e-05	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—PIK3CA—head and neck cancer	6.62e-06	5.47e-05	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—AKT1—head and neck cancer	6.24e-06	5.16e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—PIK3CA—head and neck cancer	5.91e-06	4.89e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—PTGS2—head and neck cancer	5.77e-06	4.78e-05	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—PIK3CA—head and neck cancer	5.77e-06	4.77e-05	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—PIK3CA—head and neck cancer	5.43e-06	4.49e-05	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—AKT1—head and neck cancer	5.41e-06	4.47e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—PIK3CA—head and neck cancer	5.39e-06	4.46e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—PTEN—head and neck cancer	5.04e-06	4.17e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—AKT1—head and neck cancer	4.83e-06	3.99e-05	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—AKT1—head and neck cancer	4.71e-06	3.9e-05	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—AKT1—head and neck cancer	4.44e-06	3.67e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—AKT1—head and neck cancer	4.4e-06	3.64e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—PIK3CA—head and neck cancer	3.55e-06	2.94e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—AKT1—head and neck cancer	2.9e-06	2.4e-05	CbGpPWpGaD
